Medmate Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Medmate Pharma Private Limited, with the most recent activity at the to…

2008-01-08 Cochin, Kerala Active Unlisted Active Compliant
Share
View plans
MP Medmate Pharma Private Limited
Open charges
5
7.50 cr
Closed charges
0
0.00
Total
5
7.50 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 4 6.50 cr
2 The Federal Bank Limited 1 1.00 cr
All charges (5) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100234624 Others 07 Dec 2018 23 Mar 2020 - 50.00 Lakh Open
100235005 Others 07 Dec 2018 - - 2.50 cr Open
100037533 Others 15 Feb 2016 - - 2.50 cr Open
100037538 Others 10 Dec 2015 - - 1.00 cr Open
10148113 The Federal Bank Limited 20 Feb 2009 11 Feb 2010 - 1.00 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Medmate Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Medmate Pharma Private Limited (CIN: U24239KL2008PTC021657). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Medmate Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.